Obstetric antiphospholipid syndrome
Antiphospholipid syndrome (APS) in pregnancy has a serious impact on maternal and fetal morbidity. It causes recurrent pregnancy miscarriage and it is associated with other adverse obstetric findings like preterm delivery, intrauterine growth restriction, preeclampsia, HELLP syndrome and others. The...
Autores Principales: | , , , , , , |
---|---|
Formato: | Artículo (Article) |
Lenguaje: | Inglés (English) |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://repository.urosario.edu.co/handle/10336/23166 https://doi.org/10.1016/j.autrev.2011.10.006 |
id |
ir-10336-23166 |
---|---|
recordtype |
dspace |
spelling |
ir-10336-231662022-05-02T12:37:20Z Obstetric antiphospholipid syndrome Galarza-Maldonado, Claudio Kourilovitch, Maria R. Pérez-Fernández, Oscar M. Gaybor, Mariana Cordero, Christian Cabrera, Sonia Soroka, Nikolai F. Acetylsalicylic acid Antibody Antithrombin Autoantibody Beta 2 glycoprotein 1 antibody Betamethasone Cardiolipin antibody Dalteparin Dexamethasone Enoxaparin Heparin Low molecular weight heparin Lupus anticoagulant Nadroparin Prednisolone Prednisone Unclassified drug Warfarin Antibody detection Antiphospholipid syndrome Autoimmune disease Human Hypercoagulability Laboratory test Low drug dose Morbidity Nonhuman Preconception injury Pregnancy Puerperium Review Spontaneous abortion Standardization Teratogenicity Thrombosis Vascular disease Animals Antibody-dependent cell cytotoxicity Antiphospholipid syndrome Aspirin Blood coagulation Female Heparin Humans Immunotherapy Individualized medicine Mice Pregnancy Pregnancy complications Antiphospholipid antibodies Obstetric antiphospholipid syndrome Recurrent pregnancy miscarriage animal antiphospholipid habitual Abortion Antibodies Disease models Antiphospholipid syndrome (APS) in pregnancy has a serious impact on maternal and fetal morbidity. It causes recurrent pregnancy miscarriage and it is associated with other adverse obstetric findings like preterm delivery, intrauterine growth restriction, preeclampsia, HELLP syndrome and others. The 2006 revised criteria, which is still valid, is used for APS classification. Epidemiology of obstetric APS varies from one population group to another largely due to different inclusion criteria and lack of standardization of antibody detection methods. Treatment is still controversial. This topic should include a multidisciplinary team and should be individualized. Success here is based on strict control and monitoring throughout pregnancy and even in the preconception and postpartum periods. Further research in this field and unification of criteria are required to yield better therapeutic strategies in the future. © 2011 Elsevier B.V. 2012 2020-05-26T00:00:08Z info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion 15689972 https://repository.urosario.edu.co/handle/10336/23166 https://doi.org/10.1016/j.autrev.2011.10.006 eng info:eu-repo/semantics/openAccess application/pdf instname:Universidad del Rosario |
institution |
EdocUR - Universidad del Rosario |
collection |
DSpace |
language |
Inglés (English) |
topic |
Acetylsalicylic acid Antibody Antithrombin Autoantibody Beta 2 glycoprotein 1 antibody Betamethasone Cardiolipin antibody Dalteparin Dexamethasone Enoxaparin Heparin Low molecular weight heparin Lupus anticoagulant Nadroparin Prednisolone Prednisone Unclassified drug Warfarin Antibody detection Antiphospholipid syndrome Autoimmune disease Human Hypercoagulability Laboratory test Low drug dose Morbidity Nonhuman Preconception injury Pregnancy Puerperium Review Spontaneous abortion Standardization Teratogenicity Thrombosis Vascular disease Animals Antibody-dependent cell cytotoxicity Antiphospholipid syndrome Aspirin Blood coagulation Female Heparin Humans Immunotherapy Individualized medicine Mice Pregnancy Pregnancy complications Antiphospholipid antibodies Obstetric antiphospholipid syndrome Recurrent pregnancy miscarriage animal antiphospholipid habitual Abortion Antibodies Disease models |
spellingShingle |
Acetylsalicylic acid Antibody Antithrombin Autoantibody Beta 2 glycoprotein 1 antibody Betamethasone Cardiolipin antibody Dalteparin Dexamethasone Enoxaparin Heparin Low molecular weight heparin Lupus anticoagulant Nadroparin Prednisolone Prednisone Unclassified drug Warfarin Antibody detection Antiphospholipid syndrome Autoimmune disease Human Hypercoagulability Laboratory test Low drug dose Morbidity Nonhuman Preconception injury Pregnancy Puerperium Review Spontaneous abortion Standardization Teratogenicity Thrombosis Vascular disease Animals Antibody-dependent cell cytotoxicity Antiphospholipid syndrome Aspirin Blood coagulation Female Heparin Humans Immunotherapy Individualized medicine Mice Pregnancy Pregnancy complications Antiphospholipid antibodies Obstetric antiphospholipid syndrome Recurrent pregnancy miscarriage animal antiphospholipid habitual Abortion Antibodies Disease models Galarza-Maldonado, Claudio Kourilovitch, Maria R. Pérez-Fernández, Oscar M. Gaybor, Mariana Cordero, Christian Cabrera, Sonia Soroka, Nikolai F. Obstetric antiphospholipid syndrome |
description |
Antiphospholipid syndrome (APS) in pregnancy has a serious impact on maternal and fetal morbidity. It causes recurrent pregnancy miscarriage and it is associated with other adverse obstetric findings like preterm delivery, intrauterine growth restriction, preeclampsia, HELLP syndrome and others. The 2006 revised criteria, which is still valid, is used for APS classification. Epidemiology of obstetric APS varies from one population group to another largely due to different inclusion criteria and lack of standardization of antibody detection methods. Treatment is still controversial. This topic should include a multidisciplinary team and should be individualized. Success here is based on strict control and monitoring throughout pregnancy and even in the preconception and postpartum periods. Further research in this field and unification of criteria are required to yield better therapeutic strategies in the future. © 2011 Elsevier B.V. |
format |
Artículo (Article) |
author |
Galarza-Maldonado, Claudio Kourilovitch, Maria R. Pérez-Fernández, Oscar M. Gaybor, Mariana Cordero, Christian Cabrera, Sonia Soroka, Nikolai F. |
author_facet |
Galarza-Maldonado, Claudio Kourilovitch, Maria R. Pérez-Fernández, Oscar M. Gaybor, Mariana Cordero, Christian Cabrera, Sonia Soroka, Nikolai F. |
author_sort |
Galarza-Maldonado, Claudio |
title |
Obstetric antiphospholipid syndrome |
title_short |
Obstetric antiphospholipid syndrome |
title_full |
Obstetric antiphospholipid syndrome |
title_fullStr |
Obstetric antiphospholipid syndrome |
title_full_unstemmed |
Obstetric antiphospholipid syndrome |
title_sort |
obstetric antiphospholipid syndrome |
publishDate |
2012 |
url |
https://repository.urosario.edu.co/handle/10336/23166 https://doi.org/10.1016/j.autrev.2011.10.006 |
_version_ |
1740172774625771520 |
score |
12,131701 |